Renal Cancer
Downregulation of Glycine N-Acyltransferase in Kidney Renal Clear Cell Carcinoma: A Bioinformatic-Based Screening.
December 15, 2023
Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study.
December 14, 2023
CD56 polysialylation promotes the tumorigenesis and progression via the Hedgehog and Wnt/β-catenin signaling pathways in clear cell renal cell carcinoma.
December 14, 2023
Safety and Efficacy of Second-Line TKI Plus Anti-PD1 in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World Study.
December 13, 2023
Adjuvant immunotherapy for locally advanced renal cell carcinoma.
December 12, 2023
EHD2, a novel HIF target gene, is a promising biomarker in clear cell renal cell carcinoma.
December 8, 2023
Identification of Crotonylation Metabolism Signature Predicting Overall Survival for Clear Cell Renal Cell Carcinoma.
December 8, 2023
Targeting lipid biosynthesis on the basis of conventional treatments for clear cell renal cell carcinoma: A promising therapeutic approach.
December 7, 2023
Preoperative Renal Parenchyma Volume as a Predictor of Kidney Function Following Nephrectomy of Complex Renal Masses.
December 7, 2023
Artificial intelligence-based non-invasive tumor segmentation, grade stratification and prognosis prediction for clear-cell renal-cell carcinoma.
December 6, 2023
Robotic-Assisted Partial Nephrectomy for Kidney Cancer: A Health Technology Assessment.
December 6, 2023
Impact of healthcare inequities on survival in Mexican patients with metastatic renal cell carcinoma.
December 5, 2023